SEC Filing Update: #QNCX Quince Therapeutics, Inc. : $34.35
Sector: Healthcare | YTD: π½ -94.28%
The SEC disclosed Today (14-AUG-2026) that BALYASNY ASSET MANAGEMENT LLC has INCREASED #QNCX Shares by 39.64% π’
CORMORANT ASSET MANAGEMENT, LP also reported an increase in its holdings on the same day.
* Previous Holdings: 69.97K Shares
* Current Holdings: 97.70K Shares
* Increase+27.73K
* Increased(%)+39.64%
* Ownership: 9.99%
* Estimated Investment Value: $840.28K
https://www.thinksabio.com/reports/isr/QNCXπ Institutional activity in the last 30 days for #QNCX:
β’ CORMORANT ASSET MANAGEMENT, LP β Increased holdings by 102,531 shares (14-AUG-2026)